Рациональная фармакотерапия заболеваний эндокринной системы и нарушений обмена веществ / Под общ. ред. И.И. Дедова, Г.А. Мельниченко. - М., 2006.
Сахарный диабет: Руководство для врачей / Под ред. И.И. Дедова, М.В. Шестаковой. - М.: Универсум Паблишинг, 2003.
Davis S.N., Granner D.K. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Hardman J.G., Limbird L.E., Eds. / Goodman & Gilman's The Pharmacologic Basis of Therapeutics. - 10th ed. - New York: McGraw-Hill, 2001. - Р. 1679-1714.
DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus / The Diabetes Control and Complications Trial Research. Group // New Engl. J. Med. -1993. - Vol. 329. - P. 977-986.
Lacy C.F., Armstrong L.L., Goldman M.P., Lance L.L. Drug Information Handbook. 11th ed. - Lexi-Comp., 2003.
Nathan D.M. Insulin Treatment of Type 2 Diabetes: The Real Deal // Endocrinology Rounds. - 2002. - Vol. 1 (1). - P. 1-8.
UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) // Lancet. - 1998. - Vol. 352. - P. 837-853.
Watkins P.J. ABC of diabetes. 5th ed. // B.M.J Books. - 2003.